Autor: |
Braet, Helena, Fransen, Peter-Paul, Mariën, Remco, Lollo, Giovanna, Ceelen, Wim, Vervaet, Chris, Balcaen, Lieve, Vanhaecke, Frank, Vanhove, Christian, van der Vegte, Stefan, Gasthuys, Elke, Vermeulen, An, Dankers, Patricia Y.W., De Smedt, Stefaan C., Remaut, Katrien |
Zdroj: |
ACS Applied Materials & Interfaces; 20230101, Issue: Preprints |
Abstrakt: |
Because peritoneal metastasis (PM) from ovarian cancer is characterized by non-specific symptoms, it is often diagnosed at advanced stages. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) can be considered a promising drug delivery method for unresectable PM. Currently, the efficacy of intraperitoneal (IP) drug delivery is limited by the off-label use of IV chemotherapeutic solutions, which are rapidly cleared from the IP cavity. Hence, this research aimed to improve PM treatment by evaluating a nanoparticle-loaded, pH-switchable supramolecular polymer hydrogel as a controlled release drug delivery system that can be IP nebulized. Moreover, a multidirectional nozzle was developed to allow nebulization of viscous materials such as hydrogels and to reach an even IP gel deposition. We demonstrated that acidification of the nebulized hydrogelator solution by carbon dioxide, used to inflate the IP cavity during laparoscopic surgery, stimulated the in situgelation, which prolonged the IP hydrogel retention. In vitroexperiments indicated that paclitaxel nanocrystals were gradually released from the hydrogel depot formed, which sustained the cytotoxicity of the formulation for 10 days. Finally, after aerosolization of this material in a xenograft model of PM, tumor progression could successfully be delayed, while the overall survival time was significantly increased compared to non-treated animals. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|